Investing Ideas
/
Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

BioArctic

Market Cap: SEK 27.3b

Develops biological drugs for patients with central nervous system disorders in Sweden.

BIOA B

SEK 308.00

-6.1%

39.5%